ts. dr. saiful effendi bin syafruddin

pensyarah universiti

institut biologi molekul perubatan ukm (umbi)

 effendisy@ppukm.ukm.edu.my



   Kluster Kepakaran/ Cluster of Expertise :
  • Kesihatan dan Perubatan Termaju,



  •    Biografi/ Biography :


  • Saiful Effendi Syafruddin is a Research Fellow/Senior Lecturer at the UKM Medical Molecular Biology Institute (UMBI). He holds PhD in Medical Sciences from the University of Cambridge, UK. He previously earned his Master’s in Biotechnology (Molecular Genetic) from the University of Pennsylvania, USA, and BSc. in Biotechnology from Rochester Institute of Technology, USA. His PhD project focused on elucidating the genetic and epigenetic determinants that support kidney cancer pathogenesis. Saiful Effendi research interest revolves around understanding cancer molecular dependencies, specifically in kidney cancer, with the aim to identify novel and efficient clinical strategies to fight against cancer. Having been trained in the field of cell and molecular biology, cancer biology and genetic engineering for more than a decade, he has been extensively utilizing various state-of-the-art laboratory techniques throughout his cancer research works. Several of his research works have been published in high impact journals such as Nature, Cancer Discovery, Nature Communication, and Cell.

  • m. aiman mohtar, saiful effendi syafruddin, muhammad-redha abdullah-zawawi, muhammad irfan abdul jalal, teck yew low, shing cheng tan.  (2026).  integrated approach to precision oncology.  - interdisciplinary cancer research.  407 - 427. 

     

    mohd hafiz bin baharuddin ,saiful effendi bin syafruddin ,mohamad aimanuddin bin mohtar .  (2026).  comb structured wearable metamaterial with electrical conductivity for health monitoring garment of severe patients.  -

     

    m. aiman mohtar, siti nurmi nasir, zuraini abd razak, hanif zulkhairi mohamad said, syazalina zahari, saiful effendi syafruddin.  (2026).  rna-seq analysis reveals regulatory networks driven by epcam overexpression in esophageal adenocarcinoma cells.  - peerj.  1 - 24. 

     

    chia yuh cai, saiful effendi syafruddin, m. aiman mohtar.  (2026).  strategi terapeutik berasaskan crispr: sempadan baru dalam rawatan kanser payudara.  - jurnal sains kesihatan malaysia.  92 - 105. 

     

    muhammad-redha abdullah-zawawi, shing cheng tan, m. aiman mohtar, saiful effendi syafruddin, teck yew low, muhammad irfan abdul jalal.  (2025).  unveiling cancer complexity: machine learning insights into multi-omics data.  - 51 - 69. 

     

    m. aiman mohtar, siti nurmi nasir, zuraini abd razak, hanif zulkhairi mohamad said, syazalina zahari, saiful effendi syafruddin.  (2026).  rna-seq analysis reveals regulatory networks driven by epcam overexpression in esophageal adenocarcinoma cells.  - peerj.  1 - 24. 

     

    nurul iffah mohd isa, aslah nabilah abdull sukor, saiful effendi syafruddin, mohd faizal ahmad, shahidee zainal abidin, mohd helmy mokhtar, azizah ugusman, adila a. hamid.  (2025).  rna sequencing-based profiling of differentially expressed micrornas in endothelial cells from offspring of hypertensive pregnancies: a preliminary study.  - frontiers in molecular biosciences.  1 - 17. 

     

    mohd faizal ahmad, marjanu hikmah elias, norazilah mat jin, muhammad azrai abu, saiful effendi syafruddin, ani amelia zainuddin, shah shamsul azhar, nao suzuki, abdul kadir abdul karim .  (2025).  a comparative analysis of gremlin-1 (grem1), hyaluronic acid synthetase-2 (has2), and prostaglandin-endoperoxide synthase-2 (ptgs2) expression in cumulus cells among women with diminished ovarian reserve following rescue in vitro maturation (r-ivm).  - life.  1 - 25. 

     

    mohd faizal ahmad, nurul yaqin mohd nor, mohammad mahmoud mohammad ramadneh, nurul izyani roseli, marjanu hikmah elias, norazilah mat jin, muhammad azrai abu, saiful effendi syafruddin, ani amelia zainuddin, shah shamsul azhar, nao suzuki, abdul kadir abdul karim .  (2025).  comparative analysis of rescue-in vitro-maturation (r-ivm) outcomes in women with diminished ovarian reserve (dor) versus normal ovarian reserve (nor).  - biomedicines.  1 - 13. 

     

    safaa m. naes, sharaniza ab-rahim, musalmah mazlan, saiful effendi syafruddin,m. aiman mohtar, asmaa y. abuhamad, amirah abdul rahman.  (2025).  crispr/cas9 mediated ent2 gene knockout altered purine catabolic pathway and induced apoptosis in colorectal cell lines.  - plos one.  1 - 16. 

     

    muhammad bani yamin, fazleen haslinda mohd hatta , mohd shafiq aazmi, saiful effendi syafruddin, michelle yee shuen lee, nurul hanis ramzi ,nikman adli nor hashim and nazia abdul majid.  (2025).  unravelling putative ethnic-specific obesity genetic loci in malaysian youths: a genome-wide association study.  - southeast asian journal of tropical medicine and public health.  253 - 290. 

     

    mohd faizal ahmad, marjanu hikmah elias, norazilah mat jin, muhammad azrai abu, saiful effendi syafruddin, ani amelia zainuddin, nao suzuki, shamsul azhar shah, abdul kadir abdul karim.  (2024).  gene expression profiling of hyaluronic acid synthetase 2 (has2), prostaglandin-endoperoxide synthase 2 (ptgs2) and gremlin 1 (grem1) in cumulus cells among women with diminished ovarian reserved (dor).  - mjm vol 79 supplement 3, july 2024 .  7 - 7. 

     

    kelly xue jing jong, elsa haniffah mejia mohamed, saiful effendi syafruddin, farid nazer faruqu, kumutha malar vellasamy, kamariah ibrahim, zaridatul aini ibrahim.  (2024).  il-8 and pi3k pathway influence the susceptibility of trail-sensitive colorectal cancer cells to trail-induced cell death.  - molecular biology reports.  1 - 10. 

     

    poh kuan wong, saiful effendi syafruddin, fook choe cheah, norazrina azmi, pei yuen ng, eng wee chua.  (2024).  introduction of a single-nucleotide variant, rs16851030, into the adora1 gene increased cellular susceptibility to hypoxia.  - personalized medicine.  353 - 366. 

     

    saiful effendi syafruddin, wan fahmi wan mohamad nazarie, nurshahirah ashikin moidu, bee hong soon, m. aiman mohtar.  (2021).  integration of rna-seq and proteomics data identifies glioblastoma multiforme surfaceome signature.  - bmc cancer.  1-13. 

     

    m. aiman mohtar, siti nurmi nasir, zuraini abd razak, hanif zulkhairi mohamad said, syazalina zahari, saiful effendi syafruddin.  (2026).  rna-seq analysis reveals regulatory networks driven by epcam overexpression in esophageal adenocarcinoma cells.  - peerj.  1 - 24. 

     

    mohd faizal ahmad, marjanu hikmah elias, norazilah mat jin, muhammad azrai abu, saiful effendi syafruddin, ani amelia zainuddin, shah shamsul azhar, nao suzuki, abdul kadir abdul karim .  (2025).  a comparative analysis of gremlin-1 (grem1), hyaluronic acid synthetase-2 (has2), and prostaglandin-endoperoxide synthase-2 (ptgs2) expression in cumulus cells among women with diminished ovarian reserve following rescue in vitro maturation (r-ivm).  - life.  1 - 25. 

     

    mohd faizal ahmad, nurul yaqin mohd nor, mohammad mahmoud mohammad ramadneh, nurul izyani roseli, marjanu hikmah elias, norazilah mat jin, muhammad azrai abu, saiful effendi syafruddin, ani amelia zainuddin, shah shamsul azhar, nao suzuki, abdul kadir abdul karim .  (2025).  comparative analysis of rescue-in vitro-maturation (r-ivm) outcomes in women with diminished ovarian reserve (dor) versus normal ovarian reserve (nor).  - biomedicines.  1 - 13. 

     

    muhammad bani yamin, fazleen haslinda mohd hatta , mohd shafiq aazmi, saiful effendi syafruddin, michelle yee shuen lee, nurul hanis ramzi ,nikman adli nor hashim and nazia abdul majid.  (2025).  unravelling putative ethnic-specific obesity genetic loci in malaysian youths: a genome-wide association study.  - southeast asian journal of tropical medicine and public health.  253 - 290. 

     

    safaa m. naes, sharaniza ab-rahim, musalmah mazlan, saiful effendi syafruddin,m. aiman mohtar, asmaa y. abuhamad, amirah abdul rahman.  (2025).  crispr/cas9 mediated ent2 gene knockout altered purine catabolic pathway and induced apoptosis in colorectal cell lines.  - plos one.  1 - 16. 

     

    m. aiman mohtar, saiful effendi syafruddin, muhammad-redha abdullah-zawawi, muhammad irfan abdul jalal, teck yew low, shing cheng tan.  (2026).  integrated approach to precision oncology.  - interdisciplinary cancer research.  407 - 427. 

     

    muhammad-redha abdullah-zawawi, shing cheng tan, m. aiman mohtar, saiful effendi syafruddin, teck yew low, muhammad irfan abdul jalal.  (2025).  unveiling cancer complexity: machine learning insights into multi-omics data.  - 51 - 69. 

     

    aminah suhaila haron, saiful e. syafruddin, ilie fadzilah hashim, muggunna balasubramaniam, saw keat chuan, yasmin hasnizan, nurul syafawani fizal, chong chien fung, ana masara ahmad mokhtar.  (2023).  genetic mutations and clinical diagnoses associated with increased risk of malignancy in primary immunodeficiencies.  - 235-251. 

     

    saiful effendi syafruddin, mohamad aimanuddin mohtar, tan shing cheng, nadiah abu, nor aidatulakma abdullah@muda, nurul syakima ab mutalib, chin siok fong, neoh hui min, rahman jamal, nor azian abdul murad.  (2019).  umbi initiatives on colorectal cancer biomarkers discovery.  - 19-28. 

     

    chia yuh cai, saiful effendi syafruddin, m. aiman mohtar.  (2026).  strategi terapeutik berasaskan crispr: sempadan baru dalam rawatan kanser payudara.  - jurnal sains kesihatan malaysia.  92 - 105. 

     

    nurul nadia mohamad zamberi, mohd raziff alias, m. aiman mohtar, saiful effendi syafruddin.  (2025).  aplikasi teknologi crispr/cas9 dan penyuntingan perdana dalam kajian biologi molekul dan kefungsian gen.  - jurnal sains kesihatan malaysia.  67 - 79. 

     

    azizan baharuddin, noor munirah isa, rofina yasmin othman, nurzatil sharleeza mat jalaluddin, mohd salim mohamed, abdul halim ibrahim, suzana ariff azizan, mohammad firdaus abdul aziz, angelina patrick olesen, nurmadihah takhor, nazlina ibrahim, d ravichandran a/l k dhakshinamoorthy, ahmad fidhaus arham, saiful effendi syafruddin.  (2025).  garis panduan etika bioteknologi.  -

     

    siti nur hasanah mohd yusuf, m. aiman mohtar, saiful effendi syafruddin.  (2023).  penyahkawalseliaan proses transkripsi dalam patogenesis kanser.  - majalah dewan kosmik.  50-53. 

     

    yuh cai chia, sundharavalli ramayah , nurul nadia mohamad zamberi, mohamad aimanuddin mohtar , saiful effendi syafruddin.  (2023).  crispr/cas9: teknik penyuntingan dan modifikasi gen.  - 1. 

     

    mohd hafiz bin baharuddin ,saiful effendi bin syafruddin ,mohamad aimanuddin bin mohtar .  (2026).  comb structured wearable metamaterial with electrical conductivity for health monitoring garment of severe patients.  -

     

    adila a hamid, nurul iffah mohd isa, saiful effendi syafruddin, amilia aminuddin,shahidee zainal abidin, mohd faizal ahmad, azizah ugusman.  (2025).  profiling of upregulated mirnas in endothelial cells exposed to hypertensive disorders of pregnancy: a bioinformatic analysis.  - 38th scientific meeting of the malaysian society of pharmacology and physiology (mspp). 

     

    azizan baharuddin, noor munirah isa, rofina yasmin othman, nurzatil sharleeza mat jalaluddin, mohd salim mohamed, abdul halim ibrahim, suzana ariff azizan, mohammad firdaus abdul aziz, angelina patrick olesen, nurmadihah takhor, nazlina ibrahim, d ravichandran a/l k dhakshinamoorthy, ahmad fidhaus arham, saiful effendi syafruddin.  (2025).  garis panduan etika bioteknologi.  -

     

    saiful effendi syafruddin, mohamad aimanuddin mohtar.  (2025).  crispr diy: step by step genome editing protocols in mammalian cells.  -

     

    yuh cai chia, saiful effendi syafruddin, muhammad-redha abdullah-zawawi, ted hupp, delphine fessart, m. aiman mohtar,.  (2025).  identification of upstream regulatory elements governing agr2 expression in er+ breast cancer.  - crispr 2025 new zealand. 

     

    BIOLOGY :PURE AND APPLIED SCIENCES
    Cellular and Molecular Biology, Genomics, Genetic Engineering
    Pengalaman / Experience : tahun/years(s)

    BASIC MEDICAL SCIENCES :CLINICAL AND HEALTH SCIENCES
    Cancer Biology
    Pengalaman / Experience : tahun/years(s)

    BASIC MEDICAL SCIENCES :CLINICAL AND HEALTH SCIENCES
    Cancer Genetic and Epigenetic
    Pengalaman / Experience : 8 tahun/years(s)

    BASIC MEDICAL SCIENCES :CLINICAL AND HEALTH SCIENCES
    Recombinant DNA technology and gene targeting
    Pengalaman / Experience : 10 tahun/years(s)

    MEDICAL MOLECULAR BIOLOGY :BASIC MEDICAL SCIENCES
    CRISPR Technology, Gene Editing, Genome Engineering
    Pengalaman / Experience : 10 tahun/years(s)